PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).

被引：0
|
作者：
Duan, P. [1 ]
Zhao, P. [2 ]
Zhang, L. [2 ]
机构：
[1] US FDA, Silver Spring, MD USA
[2] US FDA, Off Clin Pharmacol, Off Translat Sci, CDER, Silver Spring, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT-17
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [41] Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions Involving Inhibitory Metabolite: A Case Study of Amiodarone
    Chen, Yuan
    Mao, Jialin
    Hop, Cornelis E. C. A.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (02) : 182 - 189
  • [42] A Physiologically-Based Pharmacokinetic Modeling Approach To Predict Drug-Drug Interactions of Sonidegib (LDE225) with Perpetrators of CYP3A in Cancer Patients
    Einolf, Heidi J.
    Zhou, Jocelyn
    Won, Christina
    Wang, Lai
    Rebello, Sam
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (04) : 361 - 374
  • [43] Pharmacokinetics, Pharmacodynamics Drug Transport Physiologically-Based Pharmacokinetic Modeling to Predict Methylphenidate Exposure Affected by Interplay Among Carboxylesterase 1 Pharmacogenetics, Drug-Drug Interactions, and Sex
    Xiao, Jingcheng
    Shi, Jian
    Thompson, Brian R.
    Smith, David E.
    Zhang, Tao
    Zhu, Hao-Jie
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 111 (09) : 2606 - 2613
  • [44] Predictive Performance of Physiologically-Based Pharmacokinetic Models in Predicting Drug-Drug Interactions Involving Enzyme Modulation
    Hsueh, Chia-Hsiang
    Hsu, Vicky
    Pan, Yuzhuo
    Zhao, Ping
    CLINICAL PHARMACOKINETICS, 2018, 57 (10) : 1337 - 1346
  • [45] Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions
    Rytkonen, Jaana
    Ranta, Veli-Pekka
    Kokki, Merja
    Kokki, Hannu
    Hautajarvi, Heidi
    Rinne, Valtteri
    Heikkinen, Aki T.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 72 - 88
  • [46] Physiologically-based pharmacokinetic model of sparsentan to evaluate drug-drug interaction potential
    Patel, Nikunjkumar K.
    Chen, Kuan-Fu
    Chen, Shang-Chiung
    Liu, Kai
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (02): : 317 - 329
  • [47] Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for valproic acid and divalproex
    Conner, Todd M.
    Nikolian, Vahagn C.
    Georgoff, Patrick E.
    Pai, Manjunath P.
    Alam, Hasan B.
    Sun, Duxin
    Reed, Ronald C.
    Zhang, Tao
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 111 : 465 - 481
  • [48] Physiologically based pharmacokinetic modeling of ponatinib to describe drug-drug interactions in patients with cancer
    Morita, Tomoko O.
    Hanada, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 90 (04) : 315 - 323
  • [49] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING IN PREDICTING DRUG-DRUG INTERACTIONS FOR TELMISARTAN IN HUMANS
    Kim, Jeong Ho
    Heo, Hyunjin
    Min, Jee Sun
    Kim, Doyun
    Bae, Soo Hyeon
    Bae, Soo Kyung
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S109 - S110
  • [50] Comprehensive Evaluation of OATP- and BCRP-Mediated Drug-Drug Interactions of Methotrexate Using Physiologically-Based Pharmacokinetic Modeling
    Hwang, Sejung
    Lee, Yujin
    Jang, Yeonseo
    Cho, Joo-Youn
    Yoon, Seonghae
    Chung, Jae-Yong
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 1013 - 1022
12345